Join Us!
Join us for a full day of science, innovation and connection at the Thermo Fisher Scientific Day of Science 2026, taking place this year at the Faculty of Pharmacy, Lithuanian University of Health Sciences (LSMU) in Kaunas.
Discover new perspectives, connect with the scientific community and explore technologies and solutions designed to support research and laboratory workflows.
DARE
EVERY DAY
Because Every Bit of Science is a Big Deal
You bring the questions that push the world forward. We bring the means to help you find the answers. Together, we dare every day.
A Day Dedicated to Science
One Day. Science, Technology and Connections.
Throughout the day, participants will have opportunities to:
- Hear insights and perspectives from the scientific community
- Discover technologies and solutions for research and laboratory applications
- Meet Thermo Fisher Scientific specialists and industry experts
- Explore instruments, workflows, reagents and laboratory solutions
- Exchange ideas and connect with fellow researchers and professionals
Keynote Speakers
Hesham ElAbd, PhD
Institute of Clinical Molecular Biology (IKMB), Kiel University, Germany; Institute for Digestive Research, Lithuanian University of Health Sciences, LithuaniaPost-doctoral Researcher / Visiting Researcher
TITLE: From HLA Genetics to Antigen Discovery: Decoding Immune-Mediated Inflammatory Diseases
Human leukocyte antigen (HLA) genes represent some of the strongest genetic risk factors for immune-mediated inflammatory diseases, yet the mechanisms linking HLA variation to disease remain poorly understood. Because HLA molecules shape adaptive immune responses through antigen presentation, disease-associated alleles may provide an entry point for identifying the antigens and immune responses that drive disease.
In this talk, I will present a framework for moving from HLA genetic associations toward antigen-specific mechanisms. I will discuss how population-scale T-cell receptor sequencing and statistical analyses can identify clonotypes associated with HLA alleles, antigen exposure, and disease, thereby linking genetic association to adaptive immune responses.
Using examples from inflammatory bowel disease and primary sclerosing cholangitis, I will show how immune-repertoire analysis can be integrated with high-throughput antigen-discovery approaches, including phage immunoprecipitation sequencing, to characterize responses to microbial and viral antigens.
Finally, I will discuss what classes of antigens may underlie immune-mediated inflammatory diseases and how identifying disease-relevant antigenic drivers could advance mechanistic understanding, patient stratification, and the development of antigen-directed therapeutic strategies.
Rūta Inčiūraitė, PhD
Lithuanian University of Health Sciences, LithuaniaResearcher
TITLE: The Gut in a Dish: One Model, Many Questions, Multiple Readouts
Human intestinal organoids have emerged as versatile experimental models bridging the gap between conventional cell cultures and the complexity of human tissues. But what can we actually learn from a “gut in a dish”?
The answer depends not only on the model itself, but on the biological question, experimental configuration and readouts we choose. Patient-derived intestinal organoids preserve key molecular and functional characteristics of their tissue of origin and can be adapted into systems of increasing complexity, from three-dimensional cultures to polarized epithelial models and co-cultures.
This presentation will explore how organoid-based systems can address different questions in intestinal biology, from disease-associated molecular signatures to epithelial responses to microbial metabolites, bacterial products and therapeutic interventions. Examples will illustrate how transcriptomic and epigenetic profiling can be complemented by functional readouts of epithelial barrier integrity, inflammatory signalling and polarized responses.
By combining controlled perturbations with omics and functional phenotyping, organoids provide multiple layers of biological information – from molecular mechanisms to dynamic and patient-specific responses. Ultimately, the value of a gut in a dish lies in matching the right model, perturbation and readout to the biological question.
Solveiga Samulėnaitė, PhD
Vilnius University, LithuaniaScientist
TITLE: Gut Microbiota and miRNAs in Food Addiction: From Signatures to Functional Validation
Food addiction is characterized by compulsive consumption of highly palatable foods and loss of control over food intake, sharing behavioral and neurobiological features with substance use disorders. It has been suggested that food addiction arises from the dynamic interactions among multiple gene networks and environmental factors. Some of these factors might be the gut microbiota and circulating miRNAs, which have already been described to play a role in obesity, addictions, and other disorders.
Using a translational approach combining human studies with an operant food self-administration model in mice, we investigated gut microbiota and miRNA signatures associated with food addiction. Cross-species analyses identified Blautia and miR-29c-3p and miR-665-3p as potential protective factors.
Their functional relevance was subsequently investigated in mice. Supplementation with Blautia wexlerae led to decreased addictive-like behavior, with lower persistence of response and motivation; meanwhile, potential prebiotics lactulose and rhamnose, which were linked to increased Blautia abundance, prevented food addiction development and decreased compulsivity-like behavior. On the other hand, inhibition of miRNA-29c-3p and miRNA-665-3p resulted in enhanced vulnerability towards food addiction and increased persistence of response and compulsivity towards palatable food, respectively, suggesting that their absence might facilitate the development of food addiction.
Together, these findings identify convergent gut microbiota and miRNA signatures associated with food addiction across humans and mice and provide experimental evidence for their functional relevance. They highlight microbiota-brain interactions and miRNA-mediated mechanisms as potential targets for preventing maladaptive eating behaviors.
Jonathan Chapman, PhD
Vilnius-Utrecht Center for Advanced Disease Modelling, Faculty of Medicine, Vilnius UniversityChief Researcher
TITLE: The Gut Microbiome in Preterm Infant Health and Disease: A New Role for Clostridium Species
Early-life gut microbiome development plays a critical role in shaping short- and long-term health. Preterm infants born with <32 weeks of gestation undergo altered gut microbiome development, driven by the complex care needs arising from their physiological, anatomical and immunological immaturity.
Receipt of breast milk is the main driver of infant microbiome composition and can protect against pathologies with high risks of mortality and morbidity, through the provision of multiple bioactive factors. These include human milk oligosaccharides (HMOs), which are carbohydrates that cannot be digested by the infant host but are instead metabolised by a narrow group of gut bacteria, principally Bifidobacterium species. These strains support pathogen resistance, gut barrier function and immune development. But while HMO metabolism in Bifidobacterium is well characterised, the full scope of HMO-utilising species that colonise preterm infants remains unclear.
Through combining multi-omics and patient-derived intestinal organoid models, we show for the first time that Clostridium species isolated from preterm infants, in particular Clostridium perfringens lacking the toxin perfringolysin O (pfoA–), metabolise HMOs, producing short-chain fatty acids, tryptophan catabolites and other beneficial metabolites. Furthermore, cell-free supernatants from such C. perfringens showed inhibitory effects on common infant pathobionts, generally promoted growth of beneficial microbes, enhanced mitochondrial bioenergetic function in preterm intestine-derived organoids, and suppressed the inflammatory response in an organoid co-culture model.
These findings reveal a previously undescribed role for pfoA– C. perfringens strains in gut microbiome-mediated immune education during early life, expand our understanding of HMO-metabolising microbes and lay the groundwork for novel prebiotic and postbiotic therapies.
Elīna Pasečnaja, PhD
Thermo Fisher Scientific, Chromatography and Mass Spectrometry Research Center, LithuaniaApplication Specialist
TITLE: LC-MS/MS Determination of PFAS in Wild Baltic Grey Seal Plasma – Step by Step Workflow Development
Per-and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants that require sensitive and selective analytical methods for reliable quantification in complex biological matrices. Wildlife plasma presents additional analytical challenges due to limited sample availability, high protein and lipid content, matrix effects, and the risk of background PFAS contamination.
An LC-MS/MS workflow was developed for the determination of PFAS in wild Baltic grey seal plasma. Initial screening of 31 PFAS in pooled seal pup plasma was used to evaluate compound occurrence and select 10 target analytes for subsequent quantitative method development. The workflow was systematically optimized with particular emphasis on minimizing sample consumption, reducing matrix-related effects and analytical background, and achieving robust chromatographic and mass spectrometric performance.
The optimized method enabled quantitative analysis using only 50 µL of plasma and demonstrated stable chromatographic performance, an LOQ of 0.8 ng/mL for all target compounds, intra-day precision below 10% RSD, and recoveries of 75-125%.
The method was subsequently applied to plasma samples from wild Baltic grey seal pups and adults collected in Estonia. The resulting PFAS concentration profiles supported evaluation of age- and sex-dependent exposure patterns and demonstrated the applicability of the developed workflow to wildlife biomonitoring using limited-volume, complex biological samples.
Aistė Jekabsonė, PhD
Lithuanian University of Health Sciences, LithuaniaSenior Scientist
TITLE: Extracellular Vesicles and Particles – Our Real-Time Messengers Across the Tree of Life
Lunch-on Speakers
Malin Betsgren
Thermo Fisher Scientific, SwedenInside Sales Account Manager, Nordics & Baltics
TITLE: Pipetting Best Practices
Of all the factors that contribute to the performance of a pipette, the most critical ones are the skills and expertise of the operator.
This seminar is provided to help you achieve the best possible performance with your pipettes – from function to technique, and applications.
We will review the basics of pipetting, including:
- Different pipetting techniques and when to use them
- Quick tips and tricks to achieve better accuracy
- Factors affecting the accuracy and how you can minimize pipetting errors
- Preventing cross contamination
Steve Cole
Thermo Fisher Scientific, United KingdomCentrifugation Technical Sales Specialist
TITLE: Centrifuge and Rotor Safety
This seminar is designed to enhance laboratory safety by providing comprehensive knowledge on the use of centrifuges.
Attendees will gain a deeper understanding of centrifugation principles, properties and correct usage of rotors.
By improving knowledge in these areas, the seminar aims to significantly reduce the risk of accidents to personnel and prevent damage to laboratory equipment.
This session is essential for ensuring a safer and more efficient laboratory environment.
Agenda:
- Improve knowledge of centrifugation
- Improve knowledge of rotor properties and correct use
- Reduce the risk of accidents to personnel and damage to equipment
Isabel Naranjo, PhD
Thermo Fisher Scientific, GermanyChannel Manager
TITLE: Optimizing Cell Culture Workflows: Plastics, Media, Serum and Specialized Solutions for Reliable Results
Successful cell culture depends on the careful selection of every component of the workflow: from the culture vessel and surface to the media, supplements and serum used to support cell growth.
This session provides a practical overview of Thermo Fisher Scientific’s cell culture solutions, with a focus on Nunc™ Cell Culture Plastics, Gibco™ Cell Culture Essentials and Fetal Bovine Serum (FBS), together with specialized solutions for IVF and advanced cell culture applications.
We will explore how culture vessel design and surface characteristics can influence cell attachment, growth and reproducibility; discuss key considerations when selecting media, supplements and serum; and highlight how consistency and quality across the workflow can help reduce experimental variability.
The session will connect product selection with real laboratory workflows and provide practical guidance for researchers working across cell biology, life sciences and specialized cell culture applications.
Samy Dufour, PhD
Thermo Fisher Scientific, FranceTechnical Sales Specialist
TITLE: Comprehensive Solutions for the Formulation and Spatial Characterization of 3D Immune Models with Thermo Fisher
Three-dimensional (3D) cell culture systems, including organoids, spheroids, and tumoroids, are rapidly becoming widely used in immune modeling. By recapitulating tissue architecture, cellular heterogeneity, and diffusion-driven gradients, these models provide a physiologically relevant framework to investigate complex mechanisms such as immune cell infiltration, activation, and therapeutic response. However, standardizing both the generation and analysis of these complex microenvironments remains a key challenge.
Once established, extracting meaningful biological insights requires robust and spatially resolved characterization. Advanced imaging plays a central role by enabling both structural and functional analysis of complex 3D models. Brightfield imaging allows rapid monitoring of spheroid size and morphology, while fluorescence-based approaches enable multiplexed analysis of immune and cellular markers.
Thermo Fisher Scientific streamlines these workflows by combining high-performance imaging platforms with validated reagents, following a philosophy of user-friendly systems. Automated systems (e.g., Invitrogen™ EVOS™ M7000 Imaging System) enable fast, reproducible imaging for routine monitoring and live cell analysis.
High-content confocal screening platforms (e.g., Thermo Scientific™ CellInsight™ CX7 LZR Pro High Content Screening Platform) enable automated, multiparametric imaging of thick 3D samples. Finally, spatial imaging solutions (e.g., EVOS™ S1000 Spatial Imaging System) enable up to 9-color imaging for fast detailed tissue mapping.
Dominykas Bukelskis
Thermo Fisher Scientific, LithuaniaProduct Manager
TITLE: Building the Data Behind AI-Driven Protein Engineering
Protein research is increasingly moving from discovering useful proteins in nature toward engineering proteins with properties tailored to specific applications. Machine-learning approaches can accelerate this transition by helping researchers navigate vast protein sequence spaces and prioritize promising designs. However, these approaches depend on experimental sequence–function data, which can require substantial time, effort and resources to generate.
For many laboratories, building and testing hundreds or thousands of protein variants may therefore make AI-driven protein engineering appear difficult to access. Traditional workflows based on cloning, transformation and cell-based expression are powerful and well established, but can become a practical bottleneck as experimental scale increases.
New experimental approaches can help lower this barrier by simplifying the path from sequence design to functional testing and making parallel evaluation of protein variants more practical. This allows to create datasets at a scale that can support computationally guided protein engineering without requiring exhaustive exploration of sequence space.
By combining accessible experimental workflows with computational approaches, protein engineering can move toward a more iterative design–build–test–learn cycle—bringing data-driven protein engineering within reach of more research laboratories.
Lea Verdiere
Thermo Fisher Scientific, United KingdomTechnical Sales Specialist
TITLE: More Biology from Less Sample: Multiplex Gene and Protein Analysis with Luminex and High-Sensitivity ProQuantum Assays
Modern life science research increasingly requires the analysis of multiple biological targets while working with limited sample volumes.
This presentation will introduce complementary solutions for targeted gene and protein analysis, including Luminex® xMAP® technology, Invitrogen™ ProcartaPlex™ multiplex immunoassays, Invitrogen™ QuantiGene™ Plex gene expression assays, and Invitrogen™ ProQuantum™ high-sensitivity immunoassays.
We will explore how ProcartaPlex enables simultaneous quantification of multiple protein targets, while QuantiGene Plex provides multiplex RNA analysis using hybridization-based branched-DNA signal amplification without the need for RNA purification. ProQuantum assays offer an additional solution for highly sensitive targeted protein detection using qPCR-based readout and very low sample volumes.
Together, these technologies provide researchers with flexible approaches to obtain more biological information from precious samples and select the detection strategy best suited to their research question.
Vilmantas Pedišius
Thermo Fisher Scientific, Chromatography and Mass Spectrometry Research Center, Lithuania; Lithuanian University of Health Sciences, Faculty of Pharmacy, Department of Pharmacognosy, LithuaniaValidation Scientist
TITLE: Plantago Metabolomics by LC–Orbitrap MS: From Broad Chemical Profiling to Bioactive Candidate Discovery
Plant metabolomics is challenged by chemical diversity, in-source fragmentation, and structural isomerism. This work presents an integrated UHPLC–Orbitrap MSⁿ workflow for comprehensive characterization and bioactivity-guided prioritization of metabolites from Plantago lanceolata leaves and Plantago ovata husk.
Low-energy stepped HCD at 10/50/80% normalized collision energy improved grouping of in-source fragments by 55% in positive mode and 16% in negative mode, while bioassay-guided chromatographic fractionation was introduced to progressively reduce extract complexity and associate defined chromatographic regions with biological responses. Complementary ddMS², ddMS³, AcquireX™ Deep Scan, and Real-Time Library Search balanced metabolome coverage and annotation confidence, yielding 472 putative identifications in P. lanceolata leaves and 233 in P. ovata husk.
The workflow was subsequently extended to solvent-selected extracts, chromatographic fractions, and HUVEC-based assays measuring VCAM-1, ICAM-1, TNF-α, IL-1β, nitric oxide, reactive oxygen species, and cell viability. LC–MS features are prioritized using biological response, endothelial relevance, identification confidence, abundance, and practical isolatability. Ongoing work focuses on targeted isolation, authentic-standard confirmation, and biological re-testing of purified candidates.
This study demonstrates how advanced LC–MSⁿ metabolomics can connect broad plant chemical profiling with the early-stage discovery of biologically relevant natural products.
Robert van Ling
Thermo Fisher Scientific, NetherlandsTechnical Sales Specialist
TITLE: The Use of Innovative Separation Media and Structures for Proteomics and Therapeutic Proteins and Oligonucleotides
With the increasing challenges in complexity and throughput for large molecule samples, new approaches in separation media and structures are needed to match the requirements for identification and characterization of such samples.
This has opened the way for extra-high resolution micropillar structure columns for nanoLC and capLC columns, to target bottom-up proteomics workflows, as well as small polymeric and monodisperse particle columns for proteins and oligonucleotides, using either ion exchange or reversed phase chromatography.
In this presentation, we will discuss these innovative approaches to improve protein and oligonucleotide separations, and show examples how these approaches perform in combination with UV and MS detection.
Program
- 09:00-16:00 Foyer of 1st floor
-
Registration and Welcome coffee, tea
- 09:00-16:00 Foyer of 1st and 2nd floor
-
Exhibition and Talent Connect Zone
- 10:00-10:10 A202-A203
-
Conference Opening
Opening remarks by Prof. Juozas Kupčinskas, Vice-Rector for Research, Lithuanian University of Health Sciences, and Dr. Edita Šmergelienė, Sr. Director, Research and Development, Thermo Fisher Scientific.
- 10:10-10:50 A202-A203
-
From HLA Genetics to Antigen Discovery: Decoding Immune-Mediated Inflammatory Diseases
Hesham ElAbd, PhD (Institute of Clinical Molecular Biology (IKMB), Kiel University, Germany; Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania)
- 10:50-11:25 A202-A203
-
The Gut in a Dish: One Model, Many Questions, Multiple Readouts
Rūta Inčiūraitė, PhD (Lithuanian University of Health Sciences, Lithuania)
- 11:25-12:00 A202-A203
-
Gut Microbiota and miRNAs in Food Addiction: From Signatures to Functional Validation
Solveiga Samulėnaitė, PhD (Vilnius university, Lithuania)
- 12:00-13:30 Foyer of 2nd floor
-
Lunch
- 12:10-13:20
-
Lunch-on Seminars
- 12:15-12:45 A205
-
Pipetting Best Practices
Malin Betsgren (Thermo Fisher Scientific, Sweden)
- 12:50-13:20 A205
-
Centrifuge and Rotor Safety
Steve Cole (Thermo Fisher Scientific, United Kingdom)
- 12:15 - 12:45 A202
-
Optimizing Cell Culture Workflows: Plastics, Media, Serum and Specialized Solutions for Reliable Results
Isabel Naranjo, PhD (Thermo Fisher Scientific, Germany)
- 12:50 - 13:20 A202
-
Comprehensive Solutions for the Formulation and Spatial Characterization of 3D Immune Models with Thermo Fisher
Samy Dufour, PhD (Thermo Fisher Scientific, France)
- 12:15-12:45 A203
-
Building the Data Behind AI-Driven Protein Engineering
Dominykas Bukelskis (Thermo Fisher Scientific, Lithuania)
- 12:50-13:20 A203
-
More Biology from Less Sample: Multiplex Gene and Protein Analysis with Luminex and High-Sensitivity ProQuantum Assays
Lea Verdiere (Thermo Fisher Scientific, United Kingdom)
- 12:15-12:45 A204
-
Plantago Metabolomics by LC–Orbitrap MS: From Broad Chemical Profiling to Bioactive Candidate Discovery
Vilmantas Pedišius (Thermo Fisher Scientific, Chromatography and Mass Spectrometry Research Center, Lithuania; Lithuanian University of Health Sciences, Faculty of Pharmacy, Department of Pharmacognosy, Lithuania)
- 12:50-13:20 A204
-
The Use of Innovative Separation Media and Structures for Proteomics and Therapeutic Proteins and Oligonucleotides
Robert van Ling (Thermo Fisher Scientific, Netherlands)
- 13:30-14:10 A202-A203
-
The Gut Microbiome in Preterm Infant Health and Disease: A New Role for Clostridium Species
Jonathan Chapman (Vilnius-Utrecht Center for Advanced Disease Modelling, Faculty of Medicine, Vilnius University, Lithuania)
- 14:10-14:50 A202-203
-
LC-MS/MS Determination of PFAS in Wild Baltic Grey Seal Plasma - Step by Step Workflow Development
Elīna Pasečnaja (Thermo Fisher Scientific, Chromatography and Mass Spectrometry Research Center, Lithuania)
- 14:50-15:30 A202-A203
-
Extracellular Vesicles and Particles - Our Real-Time Messengers Across the Tree of Life
Aistė Jekabsonė (Lithuanian University of Health Sciences, Lithuania)
- 15:30-16:00 Foyer of 2nd floor
-
Networking
Exhibition
Vilnius Innovation Hub
See how Vilnius is shaping science and supporting Thermo Fisher's mission for a healthier, cleaner, and safer world.
Molecular Biology
Explore advanced sample preparation and PCR techniques and equipment like Absolute Q, VeritiPro, and E-Gel Power Snap for precise molecular research.
Protein Analysis
Investigate a comprehensive solutions for accurate protein purification, quantification, and characterization, essential for groundbreaking biochemistry and molecular biology research.
Cell Biology and Visualization
Discover our premium Fetal Bovine Serum, cell biology reagents, plastics, and the precise, user-friendly EVOS M3000 Imaging System for cellular imaging.
Chromatography and Mass Spectrophotometry
Experience our advanced solutions, crucial for the separation, identification, and quantification of complex mixtures in various scientific fields.
General Laboratory Products
Discover assortment for liquid handling, sample storage, and biological safety cabinets to optimize workflow and ensure safety.
Fisher Scientific Channel
Visit our scientific marketplace for high-quality products from leading brands and the latest in laboratory technology.
Registration
Participation in the Thermo Fisher Scientific Day of Science 2026 require advance registration. Registration will be available until October 14, 2026.
Venue
This Year, We Meet in Kaunas!
Lithuanian University of Health Sciences (LSMU)
Sukilėlių pr. 13
Kaunas, Lithuania
Event Host
Thermo Fisher Scientific
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Thermo Fisher Scientific Inc. is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
